Gisele A Beaudoin

Gisele A. Beaudoin serves as the primary procurement lead for the National Institute of Child Health and Human Development (NICHD), overseeing the acquisition of specialized research infrastructure and biotechnology services critical to advancing biomedical discovery. In this role, she manages the full lifecycle of contracts for high-precision analytical instrumentation, maintenance of sensitive laboratory equipment, and contracted research support services that enable cutting-edge studies in human development, reproductive health, and pediatric outcomes. Her work directly supports NICHD’s mission by ensuring timely access to mission-critical scientific capabilities through compliant, performance-based contracting practices. Beaudoin cultivates strategic partnerships with a broad spectrum of vendors specializing in life sciences research support, including firms offering custom assay development, bioinformatics services, and calibrated instrumentation maintenance. While no single contractor dominates her portfolio, she consistently engages with technical service providers possessing validated expertise in molecular diagnostics, lab automation, and biosafety-compliant equipment servicing. Her contracting approach emphasizes vendor qualifications, technical capability statements, and compliance with federal laboratory standards over price alone, fostering long-term, performance-driven relationships. Her procurement patterns reflect a strong preference for open competition, with 100% of acquisitions conducted under non-set-aside authorities. She does not prioritize 8(a), HUBZone, or SDVOSB set-asides, instead focusing on technical merit and capability alignment with NICHD’s high-stakes research environment. This approach ensures access to the most qualified providers, regardless of socioeconomic designation, while still complying with all federal small business goals through voluntary participation where appropriate. Beaudoin’s primary focus is NAICS 541714—Research and Development in Biotechnology—where she procures advanced services such as genomic sequencing support, cell culture optimization, proteomic analysis, and biorepository management. Her technical domain expertise lies in life sciences R&D infrastructure, with deep familiarity in regulatory frameworks governing biomedical research procurement, including FDA-aligned validation protocols and NIH biosafety guidelines.